Cowan Elvia (CIK 1960048) reported 21 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-08). Recent activity: Buy PCVX (3,000 shares), Sell PCVX (3,000 shares), Sell PCVX (1,487 shares), Sell PCVX (405 shares), Sell PCVX (495 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-08 | Vaxcyte, Inc. (PCVX) | SVP, Finance & CAO | Buy | 3,000 | $77,760 |
| 2026-04-08 | Vaxcyte, Inc. (PCVX) | SVP, Finance & CAO | Sell | 3,000 | $180,000 |
| 2026-03-18 | Vaxcyte, Inc. (PCVX) | SVP, Finance & CAO | Sell | 1,487 | $82,365 |
| 2026-03-18 | Vaxcyte, Inc. (PCVX) | SVP, Finance & CAO | Sell | 405 | $22,785 |
| 2026-03-11 | Vaxcyte, Inc. (PCVX) | SVP, Finance & CAO | Sell | 495 | $29,363 |
| 2026-03-11 | Vaxcyte, Inc. (PCVX) | SVP, Finance & CAO | Buy | 2,500 | $64,800 |
| 2026-03-11 | Vaxcyte, Inc. (PCVX) | SVP, Finance & CAO | Sell | 2,500 | $146,475 |
| 2026-03-02 | Vaxcyte, Inc. (PCVX) | SVP, Finance & CAO | Buy | 10,681 | $0 |
| 2026-03-02 | Vaxcyte, Inc. (PCVX) | SVP, Finance & CAO | Buy | 7,716 | $199,999 |
| 2026-03-02 | Vaxcyte, Inc. (PCVX) | SVP, Finance & CAO | Sell | 243 | $15,061 |
| 2026-03-02 | Vaxcyte, Inc. (PCVX) | SVP, Finance & CAO | Sell | 326 | $20,205 |
| 2025-12-29 | Vaxcyte, Inc. (PCVX) | SVP, FINANCE | Sell | 4,907 | $235,045 |
| 2025-12-29 | Vaxcyte, Inc. (PCVX) | SVP, FINANCE | Sell | 6,716 | $321,965 |
| 2025-12-29 | Vaxcyte, Inc. (PCVX) | SVP, FINANCE | Sell | 1,000 | $0 |
| 2025-09-10 | Vaxcyte, Inc. (PCVX) | SVP, FINANCE | Sell | 482 | $15,622 |
| 2025-09-04 | Vaxcyte, Inc. (PCVX) | SVP, FINANCE | Sell | 242 | $7,638 |
| 2025-09-04 | Vaxcyte, Inc. (PCVX) | SVP, FINANCE | Sell | 325 | $10,257 |
| 2025-08-29 | Vaxcyte, Inc. (PCVX) | SVP, FINANCE | Buy | 2,810 | $0 |
| 2025-03-03 | Vaxcyte, Inc. (PCVX) | SVP, FINANCE | Buy | 5,379 | $0 |
| 2025-03-03 | Vaxcyte, Inc. (PCVX) | SVP, FINANCE | Sell | 242 | $17,671 |
| 2025-03-03 | Vaxcyte, Inc. (PCVX) | SVP, FINANCE | Sell | 325 | $23,432 |
Source: SEC Form 4 filings · as of 2026-04-08